Published in J Neurol on February 03, 2010
Infliximab for patients with neuro-Behcet's disease: case series and literature review. Clin Rheumatol (2011) 0.99
[Epidemiology and clinical aspects of Adamantiades-Behçet disease in Gemany. Current data]. Ophthalmologe (2012) 0.93
Frosted branch angiitis diagnosed as neuro-behçet: a diagnostic and etiologic dilemma. Case Rep Ophthalmol (2011) 0.85
Neuro-Behçet's disease in childhood: a focus on the neuro-ophthalmological features. Orphanet J Rare Dis (2013) 0.84
Neurologic manifestations of childhood rheumatic diseases. Iran J Child Neurol (2012) 0.78
Atypical manifestations in Brazilian patients with neuro-Behçet's disease. J Neurol (2011) 0.77
Efficacy of infliximab in neuro-Behçet's disease presenting with isolated longitudinally extensive transverse myelitis. J Neurol (2013) 0.77
Update on the diagnosis and management of Behçet's disease. Open Access Rheumatol (2014) 0.75
Nummular headache and pituitary lesion: A case report and literature review. Ann Indian Acad Neurol (2013) 0.75
Efficacy of Anti-TNFα in Severe and Refractory Neuro-Behcet Disease: An Observational Study. Medicine (Baltimore) (2016) 0.75
Simultaneous involvement of nervous and gastrointestinal systems in Behçet's disease. Ann Dermatol (2012) 0.75
Neurological complications of Behçet's syndrome. J Neurol (2017) 0.75
Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology (1983) 40.64
Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease. Lancet (1990) 19.57
Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature (1994) 9.06
Behçet's disease. N Engl J Med (1999) 7.74
Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med (1994) 4.63
Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. The Neuro-Behçet Study Group. Brain (1999) 3.91
Neuro-Behçet's disease: epidemiology, clinical characteristics, and management. Lancet Neurol (2009) 3.69
EULAR recommendations for the management of Behçet disease. Ann Rheum Dis (2008) 3.37
The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore) (2003) 2.61
Behçet's syndrome: disease manifestations, management, and advances in treatment. Nat Clin Pract Rheumatol (2007) 2.29
CNS involvement in neuro-Behçet syndrome: an MR study. AJNR Am J Neuroradiol (1999) 2.05
Behçet's disease and the nervous system. J Neurol (1998) 1.92
Pathologic features of Behçet's syndrome: a review of Japanese autopsy registry data. Hum Pathol (1985) 1.85
Primary association of HLA-B51 with Behçet's disease in Ireland. Br J Ophthalmol (1997) 1.70
Neurological complications in Behçet's syndrome. Brain (1999) 1.68
Histopathology of central nervous system lesions in Behçet's disease. J Neurol Sci (2007) 1.59
Evaluation of clinical findings according to sex in 2313 Turkish patients with Behçet's disease. Int J Dermatol (2003) 1.51
Recent research into Behçet's disease in Japan. Int J Tissue React (1988) 1.49
Behçet's syndrome and the nervous system. Curr Opin Neurol (2004) 1.40
Behçet's disease: diagnostic and prognostic aspects of neurological involvement. J Neurol (2001) 1.36
Management of Behçet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behçet disease. Ann Rheum Dis (2008) 1.32
Azathioprine in Behcet's syndrome: effects on long-term prognosis. Arthritis Rheum (1997) 1.21
APC-resistance and Mnl I genotype (Gln 506) of coagulation factor V are rare in Japanese population. Thromb Haemost (1995) 1.20
Increased risk for venous thrombosis in carriers of the prothrombin G-->A20210 gene variant. Ann Intern Med (1998) 1.20
MRI findings in neuro-behçet's disease. Clin Radiol (2001) 1.15
Behçet's disease. Arthritis Res Ther (2003) 1.07
Behçet's syndrome: a report of 41 patients with emphasis on neurological manifestations. J Neurol Neurosurg Psychiatry (1998) 1.06
Neuro-Behçet's disease in Caucasians: a study of 22 patients. Eur J Neurol (2007) 1.06
Neuro-Behcet's disease: a masquerader of multiple sclerosis. A prospective study of neurologic manifestations of Behcet's disease in 96 Iranian patients. Exp Mol Pathol (2003) 1.06
Behçet's disease in Tunisia. Demographic, clinical and genetic aspects in 260 patients. Clin Exp Rheumatol (2007) 1.04
Prevalence and patterns of neurological involvement in Behcet's disease: a prospective study from Iraq. J Neurol Neurosurg Psychiatry (2003) 1.03
Neurological manifestations of Behçet's disease in a Caribbean population: clinical and imaging findings. J Neurol (2002) 0.99
Cerebrospinal fluid interleukin-6 in progressive Neuro-Behçet's syndrome. Clin Immunol Immunopathol (1997) 0.99
Effect of infliximab in progressive neuro-Behçet's syndrome. J Neurol Sci (2008) 0.94
Validation of the classification criteria commonly used in Korea and a modified set of preliminary criteria for Behçet's disease: a multi-center study. Clin Exp Rheumatol (2004) 0.93
Association of HLA-B51 and lack of association of class II alleles with Behçet's disease. Tissue Antigens (1992) 0.92
Thrombophilic risk factors and homocysteine levels in Behçet's disease in eastern Spain and their association with thrombotic events. Thromb Haemost (2006) 0.90
Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis. Arthritis Rheum (2004) 0.89
Lack of association of HLA-B*51 with a severe disease course in Behçet's disease. Rheumatology (Oxford) (2001) 0.87
The factor V Leiden mutation and the prothrombin G20210A mutation was not found in Japanese patients with pulmonary thromboembolism. Thromb Haemost (1999) 0.85
Central nervous system symptoms in patients with Behçet disease receiving cyclosporine therapy. Ophthalmology (1999) 0.84
The association between HLA B5 and ocular involvement in Behçet's disease in southern Turkey. Acta Ophthalmol (Copenh) (1992) 0.84
Serological and molecular HLA typing in Italian Behçet's patients: significant association to B51-DR5-DQw3 haplotype. Tissue Antigens (1992) 0.83
HLA-B51 and cigarette smoking as risk factors for chronic progressive neurological manifestations in Behçet's disease. Mod Rheumatol (2007) 0.81
Neuro-Behçet's disease in Japan. Neurology (1996) 0.79
The association of HLA-B5 antigen with specific manifestations of Behçet's disease. Dermatology (1994) 0.77
Neuro-Behçet's disease (isolated cerebral thrombophlebitis excluded). Clinical pattern, prognostic factors, treatment and long term follow-up. Adv Exp Med Biol (2003) 0.76
Neurological involvement in North Italian patients with Behçet disease. Rheumatol Int (2006) 0.75
Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet's disease. Nat Genet (2010) 3.24
Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet's disease susceptibility loci. Nat Genet (2010) 2.74
Prospective 10-year surveillance of human prion diseases in Japan. Brain (2010) 2.41
Depression in Japanese patients with chronic obstructive pulmonary disease: a cross-sectional study. Respir Care (2012) 2.00
Biosynthesis of wybutosine, a hyper-modified nucleoside in eukaryotic phenylalanine tRNA. EMBO J (2006) 1.95
Genome-wide association analysis identifies new susceptibility loci for Behçet's disease and epistasis between HLA-B*51 and ERAP1. Nat Genet (2013) 1.93
The mouse homolog of HEN1 is a potential methylase for Piwi-interacting RNAs. RNA (2007) 1.77
Mili and Miwi target RNA repertoire reveals piRNA biogenesis and function of Miwi in spermiogenesis. Nat Struct Mol Biol (2012) 1.70
SUVmax in FDG-PET at the biopsy site correlates with the proliferation potential of tumor cells in non-Hodgkin lymphoma. Leuk Lymphoma (2010) 1.55
Identification of ubiquitin-interacting proteins in purified polyglutamine aggregates. FEBS Lett (2004) 1.46
RNA-binding protein TLS is a major nuclear aggregate-interacting protein in huntingtin exon 1 with expanded polyglutamine-expressing cells. J Biol Chem (2007) 1.46
Impact of Corticosteroids on Mortality in Patients with Acute Respiratory Distress Syndrome: A Systematic Review and Meta-analysis. Intern Med (2015) 1.45
Absolute monocyte count in follicular lymphoma patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone. Leuk Res (2013) 1.45
Visual event-related potential changes in two subtypes of multiple system atrophy, MSA-C and MSA-P. J Neurol (2002) 1.42
Spike-wave stupor in a patient with metabolic disorder. J Clin Neurosci (2006) 1.41
Multicenter validation of scoring system of pre-transplant serum ferritin and disease risk in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic hematopoietic stem cell transplant. Leuk Lymphoma (2012) 1.40
Development of consensus statements for the diagnosis and management of intestinal Behçet's disease using a modified Delphi approach. J Gastroenterol (2007) 1.40
Prognostic factors in diffuse large B-cell lymphoma treated by risk-adopted therapy. Intern Med (2006) 1.39
Behçet disease: evolution of clinical manifestations. Medicine (Baltimore) (2011) 1.33
Modified uridines with C5-methylene substituents at the first position of the tRNA anticodon stabilize U.G wobble pairing during decoding. J Biol Chem (2008) 1.30
RanBPM, Muskelin, p48EMLP, p44CTLH, and the armadillo-repeat proteins ARMC8alpha and ARMC8beta are components of the CTLH complex. Gene (2007) 1.25
Pathology of asthma. Front Microbiol (2013) 1.25
The 2nd edition of consensus statements for the diagnosis and management of intestinal Behçet's disease: indication of anti-TNFα monoclonal antibodies. J Gastroenterol (2013) 1.23
Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations. Haematologica (2009) 1.22
Clinical characteristics of neuro-Behcet's disease in Japan: a multicenter retrospective analysis. Mod Rheumatol (2011) 1.20
Cell-cycle-dependent regulation of human aurora A transcription is mediated by periodic repression of E4TF1. J Biol Chem (2002) 1.19
Targeted resequencing implicates the familial Mediterranean fever gene MEFV and the toll-like receptor 4 gene TLR4 in Behçet disease. Proc Natl Acad Sci U S A (2013) 1.15
Remission of lymphoma after withdrawal of methotrexate in rheumatoid arthritis: relationship with type of latent Epstein-Barr virus infection. Am J Hematol (2007) 1.14
The RNA-binding protein FUS/TLS is a common aggregate-interacting protein in polyglutamine diseases. Neurosci Res (2009) 1.13
Prognostic impact of extranodal involvement in diffuse large B-cell lymphoma in the rituximab era. Cancer (2011) 1.13
PIWI Expression and Function in Cancer. Front Genet (2012) 1.12
Adenovirus-mediated transfer and overexpression of heme oxygenase 1 cDNA in lung prevents bleomycin-induced pulmonary fibrosis via a Fas-Fas ligand-independent pathway. Hum Gene Ther (2002) 1.12
Increased serum HO-1 in hemophagocytic syndrome and adult-onset Still's disease: use in the differential diagnosis of hyperferritinemia. Arthritis Res Ther (2005) 1.11
Structural and functional characterization of the USP11 deubiquitinating enzyme, which interacts with the RanGTP-associated protein RanBPM. Biochem J (2002) 1.11
Central nervous system involvement in diffuse large B-cell lymphoma. Eur J Haematol (2010) 1.11
Bone erosions in rheumatoid arthritis can be repaired through reduction in disease activity with conventional disease-modifying antirheumatic drugs. Arthritis Res Ther (2006) 1.11
Expression of heme oxygenase-1 in human leukemic cells and its regulation by transcriptional repressor Bach1. Cancer Sci (2010) 1.10
Exome sequencing reveals a homozygous SYT14 mutation in adult-onset, autosomal-recessive spinocerebellar ataxia with psychomotor retardation. Am J Hum Genet (2011) 1.10
Resolution of psoriasis following allogeneic bone marrow transplantation for chronic myelogenous leukemia: case report and review of the literature. Am J Hematol (2002) 1.10
Transactivation of MCP-1/CCL2 by beta-catenin/TCF-4 in human breast cancer cells. Int J Cancer (2006) 1.09
Prognostic value of integrin beta1-ILK-pAkt signaling pathway in non-small cell lung cancer. Hum Pathol (2007) 1.08
Transfer RNA as a source of small functional RNA. J Mol Biol Mol Imaging (2015) 1.08
Trends in transmitted drug-resistant HIV-1 and demographic characteristics of newly diagnosed patients: nationwide surveillance from 2003 to 2008 in Japan. Antiviral Res (2010) 1.08
CpG oligodeoxynucleotides enhance neonatal resistance to Listeria infection. J Immunol (2005) 1.08
Heme oxygenase-1, a potential biomarker of chronic silicosis, attenuates silica-induced lung injury. Am J Respir Crit Care Med (2006) 1.08
European Treatment and Outcome Study score does not predict imatinib treatment response and outcome in chronic myeloid leukemia patients. Cancer Sci (2014) 1.08
Mitochondrial protein BmPAPI modulates the length of mature piRNAs. RNA (2013) 1.07
Net positive charge of HIV-1 CRF01_AE V3 sequence regulates viral sensitivity to humoral immunity. PLoS One (2008) 1.07
Bach1 regulates osteoclastogenesis in a mouse model via both heme oxygenase 1-dependent and heme oxygenase 1-independent pathways. Arthritis Rheum (2012) 1.06
Primary hepatic peripheral T-cell lymphoma treated with corticosteroid. Intern Med (2011) 1.06
Power Doppler ultrasonography is useful for assessing disease activity and predicting joint destruction in rheumatoid arthritis patients receiving tocilizumab--preliminary data. Rheumatol Int (2011) 1.05
Association of human leukocyte antigen with interstitial lung disease in rheumatoid arthritis: a protective role for shared epitope. PLoS One (2012) 1.05
Cytokine production profile in patients with Behcet's disease treated with infliximab. Cytokine (2003) 1.05
Affixin interacts with alpha-actinin and mediates integrin signaling for reorganization of F-actin induced by initial cell-substrate interaction. J Cell Biol (2004) 1.03
Peripheral blood absolute lymphocyte/monocyte ratio as a useful prognostic factor in diffuse large B-cell lymphoma in the rituximab era. Eur J Haematol (2013) 1.02
Induction of epithelial progenitors in vitro from mouse embryonic stem cells and application for reconstruction of damaged cornea in mice. Invest Ophthalmol Vis Sci (2004) 1.02
Sensitivity and specificity of the Streptococcus pneumoniae urinary antigen test for unconcentrated urine from adult patients with pneumonia: a meta-analysis. Respirology (2013) 1.01
Txk, a member of nonreceptor tyrosine kinase of Tec family, acts as a Th1 cell-specific transcription factor and regulates IFN-gamma gene transcription. J Immunol (2002) 1.01
Central nervous system event in patients with diffuse large B-cell lymphoma in the rituximab era. Cancer Sci (2011) 1.00
The first CH domain of affixin activates Cdc42 and Rac1 through alphaPIX, a Cdc42/Rac1-specific guanine nucleotide exchanging factor. Genes Cells (2004) 1.00